Trial Profile
Investigation of usefulness of molecular functional imaging to observe vascular remodeling and tumor oxygenation of breast cancer after start of eribulin mesylate
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer
- Focus Pharmacodynamics
- 16 May 2016 New trial record
- 03 May 2016 Results of pooled analysis published in the British Journal of Cancer